PCM
Polaris Capital Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.3M | Sell |
152,644
-11,000
| -7% | -$2.04M | 1.89% | 27 |
|
2025
Q1 | $34.3M | Sell |
163,644
-64,235
| -28% | -$13.5M | 1.96% | 18 |
|
2024
Q4 | $40.5M | Sell |
227,879
-7,500
| -3% | -$1.33M | 1.95% | 14 |
|
2024
Q3 | $46.5M | Buy |
235,379
+900
| +0.4% | +$178K | 2.29% | 10 |
|
2024
Q2 | $40.2M | Sell |
234,479
-3,800
| -2% | -$652K | 2.16% | 15 |
|
2024
Q1 | $43.4M | Sell |
238,279
-57,800
| -20% | -$10.5M | 2.16% | 12 |
|
2023
Q4 | $45.9M | Sell |
296,079
-7,900
| -3% | -$1.22M | 2.22% | 9 |
|
2023
Q3 | $45.3M | Sell |
303,979
-115,037
| -27% | -$17.1M | 2.44% | 6 |
|
2023
Q2 | $56.5M | Sell |
419,016
-1,542
| -0.4% | -$208K | 2.12% | 15 |
|
2023
Q1 | $67M | Hold |
420,558
| – | – | 2.5% | 6 |
|
2022
Q4 | $68M | Sell |
420,558
-1,000
| -0.2% | -$162K | 2.37% | 8 |
|
2022
Q3 | $56.6M | Sell |
421,558
-7,557
| -2% | -$1.01M | 2.22% | 10 |
|
2022
Q2 | $65.7M | Sell |
429,115
-32,300
| -7% | -$4.95M | 2.35% | 7 |
|
2022
Q1 | $74.8M | Sell |
461,415
-23,000
| -5% | -$3.73M | 2.38% | 7 |
|
2021
Q4 | $65.6M | Sell |
484,415
-700
| -0.1% | -$94.8K | 2.12% | 16 |
|
2021
Q3 | $52.3M | Buy |
485,115
+60,300
| +14% | +$6.5M | 1.67% | 25 |
|
2021
Q2 | $47.9M | Buy |
424,815
+5,100
| +1% | +$574K | 1.54% | 30 |
|
2021
Q1 | $48.8M | Sell |
419,715
-30,600
| -7% | -$3.56M | 1.6% | 30 |
|
2020
Q4 | $48.3M | Buy |
450,315
+359,700
| +397% | +$38.5M | 1.81% | 22 |
|
2020
Q3 | $7.94M | Sell |
90,615
-316
| -0.3% | -$27.7K | 0.39% | 41 |
|
2020
Q2 | $8.93M | Buy |
+90,931
| New | +$8.93M | 0.44% | 41 |
|